Skip to main content
Login
Contact
Subscribe
Search form
Search
Mammoth Times
Click for weather forecast
Home
Forms
News
Obituaries
Sports/Outdoors
Classifieds
Place an Ad
Photos
Videos
Games
Mountain
Snow Report
Ski Report
Road Conditions
Entertainment
Local Guide
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
Standard & Poors 500
New York Composite
Gold
Crude Oil
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries
Albireo Pharma Inc
(NQ:
ALBO
)
37.68
USD
+1.30 (+3.57%)
Streaming Delayed Price
Updated: 1:35 PM EST, Jan 26, 2021
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All news about Albireo Pharma Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Albireo Announces U.S. FDA Acceptance of New Drug Application for Odevixibat
January 25, 2021
From
GlobeNewswire News Releases
Albireo Recognizes International Alagille Syndrome Awareness Day 2021
January 22, 2021
Albireo supports the Alagille syndrome community to advocate for more education and new treatment advances for rare cholestatic liver diseases
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 14, 2021
From
GlobeNewswire News Releases
Albireo to Host Virtual Investor Commercial Day 2021
January 07, 2021
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
January 06, 2021
From
GlobeNewswire News Releases
Albireo to Participate in H.C. Wainwright BioConnect and LifeSci Advisors Investor Conferences
January 05, 2021
From
GlobeNewswire News Releases
Albireo Initiates Global Phase 3 Clinical Trial of Odevixibat in Alagille Syndrome
December 17, 2020
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
December 11, 2020
From
GlobeNewswire News Releases
Albireo Submits for U.S. FDA and EMA Product Approval of Once-Daily Odevixibat for PFIC
December 08, 2020
From
GlobeNewswire News Releases
How The Parts Add Up: DWAS Headed For $77
November 18, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
The Week Ahead In Biotech: The Vaccine Updates, Drug Presentations, And FDA Decisions That Will Move The Markets
November 15, 2020
Biotech stocks advanced in the week ended Nov. 13 amid a vaccine news flow-induced rally that also lifted the broader market. The ...
Tags
LCTX
Benzinga
JAGX
From
Benzinga
New Phase 3 Data at AASLD Show Durable Response to Odevixibat in a Rare Pediatric Liver Disease
November 13, 2020
From
GlobeNewswire News Releases
Albireo to Participate in Jefferies and Piper Sandler Virtual Investor Conferences
November 12, 2020
From
GlobeNewswire News Releases
Albireo Reports Q3 2020 Financial Results and Provides Business Update
November 05, 2020
From
GlobeNewswire News Releases
Albireo’s Odevixibat PFIC Phase 3 Results Accepted for AASLD Late-Breakers
November 02, 2020
From
GlobeNewswire News Releases
Albireo Announces Presentations at NASPGHAN 2020 Annual Meeting
October 23, 2020
From
GlobeNewswire News Releases
Cramer Gives His Opinion On Cloudera, Barrick Gold And More
October 20, 2020
On CNBC's "Mad Money Lightning Round," Jim Cramer said Zuora Inc (NYSE: ZUO) is struggling because it has real ...
Tags
Media
ALBO
TMO
From
Benzinga
IEIH's Holdings Imply 17% Gain Potential
October 14, 2020
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and...
Tags
ETFs
From
ETF Channel
Albireo Recognizes PFIC Awareness Day 2020
October 05, 2020
Albireo stands together with the PFIC community to highlight critical need for education and advances in research for rare cholestatic liver diseases
From
GlobeNewswire News Releases
Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
October 02, 2020
From
GlobeNewswire News Releases
First Week of November 20th Options Trading For Albireo Pharma
September 24, 2020
Investors in Albireo Pharma Inc (ALBO) saw new options begin trading this week, for the November 20th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ALBO...
Tags
Stocks
From
Market News Video
Notable Insider Buys of the Past Week: Nikola, Transdigm And More
September 20, 2020
Insider buying can be an encouraging signal for potential investors when markets are near all-time highs. One ...
Tags
Insider Trades
CRY
Alcoa
From
Benzinga
Insider Buys Albireo Pharma's Shares
September 15, 2020
Perceptive Advisors Llc filed a Form 4 with the SEC on Tuesday, September 15. The insider bought 400,000 shares of Albireo Pharma Inc ...
Tags
Benzinga
Insider Trade
ALBO
From
Benzinga
Investors Land ALBO Even Cheaper Than Its Secondary Stock Offering
September 11, 2020
Looking back to 2 days ago, Albireo Pharma Inc (ALBO) priced a 4,000,000 share secondary stock offering at $40.00 per share. Buyers in that offering made a considerable investment into the company,...
Tags
Stocks
From
Market News Video
Albireo Prices Public Offering of 4,000,000 Shares of Common Stock
September 09, 2020
From
GlobeNewswire News Releases
44 Stocks Moving in Wednesday's Pre-Market Session
September 09, 2020
Gainers Superconductor Technologies Inc (NASDAQ: SCON) rose 45.8% to $0.35 in pre-market trading after declining 7% on Tuesday. ...
Tags
SCON
CHEK
SRG
From
Benzinga
64 Biggest Movers From Yesterday
September 09, 2020
Gainers Luby's, Inc. (NYSE: LUB) rose 111.4% to close at $2.22 on Tuesday. Luby's board adopted plan of liquidation and ...
Tags
IBEX
Markets
FTSI
From
Benzinga
Albireo Pharma Joins Elite Club Of Stocks With RS Ratings Over 90
September 09, 2020
Albireo Pharma sees its Relative Strength Rating reach the elite 90-plus level.
From
Investor's Business Daily
Albireo Announces Proposed Public Offering of 3,000,000 Shares of Common Stock
September 08, 2020
From
GlobeNewswire News Releases
Mid-Afternoon Market Update: Dow Falls 1.5%; Nikola Shares Surge
September 08, 2020
Toward the end of trading Tuesday, the Dow traded down 1.54% to 27699.01 while the NASDAQ fell 3.06% to 10967.25. The S&P also fell, ...
Tags
Global
CODX
Benzinga
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
X
Username
*
Password
*
Request new password